Government Mandates Doctor's Prescription For Cough Syrups Amid Tighter Regulatory Oversight
New regulations restrict cough syrup sales without prescriptions.
The Union Ministry of Health and Family Welfare has amended drug regulations to prohibit the sale of syrups, including cough syrups, without a doctor’s prescription, as part of efforts to strengthen oversight of syrup-based medicines. The amendment, notified through the Drugs (Fifth Amendment) Rules, 2026, came into effect immediately upon its publication in the official gazette.
According to official sources, the move is aimed at bringing liquid oral formulations under stricter regulatory scrutiny and improving monitoring of their manufacture, distribution and sale. The government believes the change will help enhance accountability across the pharmaceutical supply chain while ensuring greater compliance with quality and safety standards.
The amendment modifies provisions under the Drugs Rules, 1945, by removing the word “syrups” from Item 7 in the “Class of Drugs” column of Schedule K. Schedule K contains categories of medicines that are exempt from certain provisions related to manufacture, sale and distribution under the Drugs and Cosmetics Act and related rules, subject to specific conditions. By deleting syrups from this category, the government has effectively tightened regulatory requirements governing their sale.
Also Read: Health Ministry Focuses On Early Detection And Better Care For Childhood Cancer
The decision follows a draft notification issued by the ministry in December last year, inviting objections and suggestions from stakeholders. Officials said comments received from industry representatives, healthcare professionals and members of the public were reviewed before the amendment was finalised. The proposal was also examined in consultation with the Drugs Technical Advisory Board (DTAB), the country's highest statutory body on technical matters relating to pharmaceuticals.
The regulatory change comes amid heightened scrutiny of cough syrups and other liquid medicines in recent years. Concerns over the safety of certain formulations intensified following reports linking contaminated cough syrups manufactured in India to the deaths of children in several countries. The incidents prompted domestic and international regulators to call for stronger quality-control measures and stricter monitoring of pharmaceutical products.
Officials said the latest amendment is expected to improve traceability and regulatory supervision of syrup-based medicines by ensuring that manufacturers, distributors and retailers adhere to more stringent licensing and compliance requirements. The government believes the measure will contribute to safer pharmaceutical practices while reinforcing public confidence in medicines available in the market. Patients seeking cough syrups and similar formulations will now be required to obtain a valid prescription from a registered medical practitioner before purchasing them.
Also Read: Technical Glitch Prompts Midair Turnaround Of Kannur-Jeddah Air India Express Flight
